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LETTERS TO THE EDITOR 
Bleeding Complications and rt-PA 
Roth the title and abstmc, of the repan on ,he Thmmbalyrir in 
Myoswdial lnfarc,ion “WI) trial Vvfoeller et 31. [II, deflect the 
r&r from ih ccntml compelling message: 40% of those treated 
wi,h recombmxd tissue-type Qlasminogen aclivalor W-PA) had 
rignilicom hemorrhage and 22% required blood transfusions. 
Allhougk the authors. in rhrir conclusion, discuss ,he risk oi 
bleeding. the ude of Lheir ankle does no, mention Ihis. and the 
absrrac, merely says “the frequency of bleeding complicalions was 
similar in the four rfudy groups.” Nowhere else in the abstract is 
lhem any mcndon of how ofwn bleeding oecorred. In my view, 
Ulere are serious omissions that do a disservice lo the praclicing 
cordiolog.,. Uofonunxely. same less ulan meficulous readers will 
asrome lha, hemorrhage is no, a major problem in lhis gmop. 
particularly if the body of the paper is only skimmed. 
We need 10 know both ,he risks and the benefils of intewen,ion?d 
,hcnQy in acu,e infarction. The spccolation of Muellere, al. may be 
bxe: ,ha, many of dwre bleeding evems are reia,ed 10 v&w~lar 
intrusion. This seems reasonable bu, needs &sling. “ati ,ha, hap 
pens. I cannot. in good cons&we. recommend n.PA 10 my patiena 
knowing fha, the only data available indica,e a hemorrhage m,e of 
4wb and a need for blond Wansfurion in 22% lwilb ks cansequen, 5 IO 
IG% risk of hepadtisl. ptiiculady when Be advantages of ropcrfu. 
sion are eqoivoeal. a, bes,. in patients wifh inferior infection. 
The Qrersoms lo doss over onwelcnme dala most bc enormous; 
oor~oomals and their editorial staffs be.u a heavy rcrpansibility in 
making sore ,his dam’, happen. 
complics,ions. They all indicaled that hemorrhagic wen,s occurred 
in >1D% of palients, and rho, 76% of evcn,~ were obwvcd 1 
cs!he,eriza,ion or olhsr vascular Qonclom sires. They also repor@d 
tha, the frequency of blocding complicafionr was companblc 
whelher n-PA or ~Veptokinase WBJ adminiswed W. 51. A repan 
6) dealing soiely wkk hemorrhagic events and cbangcs in proteins 
of Ihe hbrinolytis system .&or rl-PA or streptokinaa infusion was 
~eently published. The resuks oflhe Thrombolysis and Angioplasly 
in Myoardial Infarction (TAMI) study (7), also combining *-PA 
and coronary wioplasfy, were similw to those of oar Wdy. 
Bleeding complications occurred in 38% of pa,ien,s with the major- 
ity of events a, vascular ponc,un sites. 
I, SQpCarS *hat hemorrhagic eve”,8 we frequent when Worn- 
bolyris is combined wilh invasive proadorer. ‘The corr~ntly ongc~ 
ing TIMI II trial. including infusion of n-PA alone and in combina- 
lion wilh immediate or deferred angioplasty. will provide impor,md 
information about ,he impact of procedures on bleeding complica- 
Lions. 
We agree tha, repon oi bleeding complications is importan,. The 
main purpose of the article was the comparison of two forms of 
wombinant tirruc-lype plarminogen activalor (n-PA) in terms of 
potency of coronary recanaliration. Anor the ini,ial encouraging 
rosol,s wi,h n-PA on which ,he Tbmmbolysis in Myocxdial Inforc- 
lion (TIM11 invosligalors reported (1.2). Gcnenlech changed the 
prcpara,ion from a liquid excipien, ,o a lyopbilized form. Because 
Le production method of n-PA differed in impanon, aspects, 
foflhcr ,w,ing WE esrwial before ,he initiation oftbe large TIMI If 
Irial. Our paper contains IWO large lahlos on bleeding complications, 
which arc easily appwn,. Rrthor, since the beginning ofthe TIMl 
s,udy. several published anicles (I-5) have described bleeding 
Retrograde Left Ventricular Flow During 
Early Relaxation 
Sasson el al. (1) described the Dopplsr characlairtics of ntmgrade 
blood Row within the Ief, ventricle during isovolumic ;olaxaion. 
They analyzed won groups of pdierds ud some nomml subjects 
and also reviewed lef, ventricular angiograrns in 13 patients. Careful 
documenbaion of those data allowed Ihem lo inlerpre, the unduly_ 
ing mechanism of this retrograde len ventricular blood Row. 
